Clinical Trials for Inflammatory Disorders by Using a GPCR19 Agonist

Time: 11:30 am
day: Day Two

Details:

• GPCR19 and Alzheimer’s disease
• GPCR19 and atopic dermatitis
• GPCR19 and COVID-19 pneumonia

Speakers: